Revance Therapeutics Inc (RVNC)

[vinmantoo]

In the daxi trials rates of headaches on placebo were 2 percent vs 6 percent but numbers are small so data can be noisy (4 headaches between the 2 RCTs out of 200 or so)

\

dewophile, thanks for the data and the links. There were 4 moderate headaches out of 406 patients in both Daxi trials total and the placebo had 2 moderate headaches out of 203 patients in both trials total. That means Daxi and placebo were both at 1%. There were no severe headaches in either group. I used the moderate headache data because I doubt that a mild headache would stop someone from getting a second free treatment.